Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
The source supplies the latest action, but no lifecycle stage.
Latest action (29 Jul 2011): Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S5076-5077)
What this bill does
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 would amend Medicare to extend coverage of immunosuppressive drugs for kidney transplant patients. Individuals whose Medicare Part A benefits have ended because of a kidney transplant or the end of dialysis would be eligible to enroll in Medicare Part B specifically for this drug coverage.
Under this bill, these individuals would pay a monthly premium for this specialized Medicare Part B coverage. This premium would be set at 35% of the monthly actuarial rate for Medicare enrollees age 65 and over. The bill also outlines a formula for a government contribution to help cover these premiums.
This bill was introduced in the Senate in July 2011 and referred to the Committee on Finance. It has not progressed further according to the provided status update.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 - Amends title II (Old Age, Survivors and Disability Benefits) (OASDI) of the Social Security Act (SSA) to extend the months of coverage of immunosuppressive drugs for kidney transplant patients.
Amends SSA title XVIII (Medicare) to make eligible for enrollment in Medicare part B (Supplementary Medical Insurance), solely for the purpose of such drug coverage, every individual whose insurance benefits under Medicare part A (Hospital Insurance) have ended by reason of a kidney transplant or the end of any requirement for a regular course of dialysis.
Directs the Secretary of Health and Human Services (HHS) to determine a monthly premium rate for such individuals equal to 35% of the monthly actuarial rate for enrollees age 65 and over. Prescribes a formula for detemination of a government contribution to such a premium.
Timeline
29 Jul 2011
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S5076-5077)
Common questions
- What does S. 1454 do?
- The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 would amend Medicare to extend coverage of immunosuppressive drugs for kidney transplant patients. Individuals whose Medicare Part A benefits have ended because of a kidney transplant or the end of dialysis would be eligible to enroll in Medicare Part B specifically for this drug coverage. Under this bill, these individuals would pay a monthly premium for this specialized Medicare Part B coverage. This premium would be set at 35% of the monthly actuarial rate for Medicare enrollees age 65 and over. The bill also outlines a formula for a government contribution to help cover these premiums. This bill was introduced in the Senate in July 2011 and referred to the Committee on Finance. It has not progressed further according to the provided status update.
- Has S. 1454 become law?
- The source does not supply a confirmed lifecycle stage for S. 1454. Check the latest action and official source below.
- Who sponsored S. 1454?
- S. 1454 was sponsored by Sen. Durbin, Richard J. [D-IL] (D-IL), with 21 cosponsors.
- What's the latest action on S. 1454?
- Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S5076-5077) (29 Jul 2011).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Durbin, Richard J. [D-IL]
National Archives Protection Act
Lead-Safe Housing for Kids Act of 2026
Judicial Space and Facilities Management Effectiveness Act of 2026
A resolution commending the Chicago Cubs baseball teams as it celebrates its 150th anniversary on August 29, 2026.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.